Moher D, Liberati A, Tetzlaff J, Altman DG, 2009 Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097.
doi:10.1371/journal.pmed.1000097
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000097
The PRISMA Statement (Preferred Reporting Items for Systematic reviews and Meta-Analyses) is a new revised guideline for reporting systematic reviews and meta-analyses http://www.prisma-statement.org/. PRISMA should supersede the existing QUOROM Statement; journals and other organisations are therefore encouraged to update their instructions and resources and refer to these new guidelines. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. Papers on
PRISMA guideline have been published simultaneously in several journals (in short and long versions) including BMJ, Journal of Clinical Epidemiology, Open Medicine, Annals of Internal Medicine.
doi:10.1371/journal.pmed.1000097
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000097
The PRISMA Statement (Preferred Reporting Items for Systematic reviews and Meta-Analyses) is a new revised guideline for reporting systematic reviews and meta-analyses http://www.prisma-statement.org/. PRISMA should supersede the existing QUOROM Statement; journals and other organisations are therefore encouraged to update their instructions and resources and refer to these new guidelines. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. Papers on
PRISMA guideline have been published simultaneously in several journals (in short and long versions) including BMJ, Journal of Clinical Epidemiology, Open Medicine, Annals of Internal Medicine.
Comments